Physician

Travis L Figanbaum, M.D.

According to 2025 Medicare claims, Travis Figanbaum, M.D. (NPI: 1881603165) practices nephrology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is RENALCARE ASSOCIATES, S.C. (NPI: 1649300377; TIN: 370995483) and primary practice location at 61265-6898. Figanbaum is affiliated with the IRCCO (ACO ID: A2619), OSF Healthcare System (ACO ID: A3289), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), SBL accountable care organization (ACO ID: A5147), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Figanbaum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 645 traditional Medicare patients, billed 2,323 HCPCS/CPT codes, and received $187,878 in Medicare payments. The top billing code was 90966 (Home dialysis services per month (20 years or older)). Part D data shows 3,318 prescription claims across 589 beneficiaries totaling $388,032 in drug costs, led by Jardiance (Empagliflozin). DME data shows 92 claims. Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $287,943 to $187,878. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $112,781 and ending at $388,032. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$161K$322K2015 Medicare payment: $287,943 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $321,955 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $259,393 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $255,909 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $268,859 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $268,650 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $297,567 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $216,486 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $190,346 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $187,878 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201597914,691$287,943
201685013,508$321,955
20179135,279$259,393
20189262,190$255,909
20199402,181$268,859
20201,0162,160$268,650
20218922,057$297,567
20227871,813$216,486
20237321,694$190,346
20246452,323$187,878

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$203K$405K2015 Drug cost: $112,781 (USD; Tot_Drug_Cst)2016 Drug cost: $361,784 (USD; Tot_Drug_Cst)2017 Drug cost: $405,080 (USD; Tot_Drug_Cst)2018 Drug cost: $283,714 (USD; Tot_Drug_Cst)2019 Drug cost: $291,831 (USD; Tot_Drug_Cst)2020 Drug cost: $191,237 (USD; Tot_Drug_Cst)2021 Drug cost: $304,009 (USD; Tot_Drug_Cst)2022 Drug cost: $312,808 (USD; Tot_Drug_Cst)2023 Drug cost: $268,374 (USD; Tot_Drug_Cst)2024 Drug cost: $388,032 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153431,963$112,781
20164293,034$361,784
20174663,088$405,080
20184692,581$283,714
20194842,438$291,831
20205102,263$191,237
20216012,839$304,009
20225983,220$312,808
20235753,107$268,374
20245893,318$388,032

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.3K$2.7K2023 Medicare payment: $2,667 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,613 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R64$2,667
2024N/R92$2,613

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90966Home dialysis services per month (20 years or older)44105$218
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more101140$77
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes90198$58
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more389609$57
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's440723$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin1067,505$145,593
FarxigaDapagliflozin Propanediol1104,314$80,614
AuryxiaFerric Citrate14780$44,306
LokelmaSodium Zirconium Cyclosilicate271,104$19,421
Sevelamer CarbonateSevelamer Carbonate693,710$15,867

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7518Mycophenolic acid, oral, 180 mgNN/R24$1,538
J7507Tacrolimus, immediate release, oral, 1 mgNN/R11$389
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R19$339
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R27$339
J7512Prednisone, immediate release or delayed release, oral, 1 mgNN/R11$9

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$14NXSTAGE MEDICAL, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

Explore More Providers

FAQ

What Medicare data is available for Travis L. Figanbaum, M.D.?

Tedicare shows public-source Medicare data for Travis L. Figanbaum, M.D. (NPI 1881603165), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Travis L. Figanbaum, M.D. have ACO affiliation data?

Travis L. Figanbaum, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), OSF Healthcare System (MSSP, ACO ID A3289), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), SBL accountable care organization (MSSP, ACO ID A5147), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Travis L. Figanbaum, M.D.?

Travis L. Figanbaum, M.D. is linked to RENALCARE ASSOCIATES, S.C. (billing NPI 1649300377) in the available physician profile data.

Does Travis L. Figanbaum, M.D. have Open Payments data?

Travis L. Figanbaum, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.